Targeting RAC1 in glioblastoma: prognostic value, immune landscape, and small molecule therapeutic potential - Poll - MDSpire

Targeting RAC1 in glioblastoma: prognostic value, immune landscape, and small molecule therapeutic potential

  • By

  • Qionghui Wu

  • Shanlin Chen

  • Xiaodong Xie

  • Xinli Feng

  • Zhenchang Zhang

  • Gang Su

  • June 18, 2026

  • 0 min

Share

Original Source(s)

Targeting RAC1 in glioblastoma: prognostic value, immune landscape, and small molecule therapeutic potential

  • by Qionghui Wu, Shanlin Chen, Xiaodong Xie, Xinli Feng, Zhenchang Zhang, Gang Su

  • June 18, 2026

Related Content

Homologous recombination pathway alterations in basal-like breast cancer

PTHrP-associated hypercalcemia in gynecologic malignancies: a scoping review

Editorial: Innovative strategies in overcoming glioblastoma: advancements in treatment and research